SI
FBT icon

Stephens Inc’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Stephens Inc’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Hold
1,494
– – ﹤0.01% 995
2026
Q1 		$300K Hold
1,494
– – ﹤0.01% 1036
2025
Q4 		$309K Hold
1,494
– – ﹤0.01% 1026
2025
Q3 		$268K Sell
1,494
-14
-0.9% -$2.38K ﹤0.01% 1097
2025
Q2 		$243K Sell
1,508
-633
-30% -$101K ﹤0.01% 1098
2025
Q1 		$364K Sell
2,141
-85
-4% -$14.8K 0.01% 918
2024
Q4 		$370K Hold
2,226
– – 0.01% 938
2024
Q3 		$383K Sell
2,226
-576
-21% -$95.3K 0.01% 933
2024
Q2 		$431K Buy
2,802
+35
+1% +$5.25K 0.01% 860
2024
Q1 		$425K Hold
2,767
– – 0.01% 879
2023
Q4 		$437K Sell
2,767
-363
-12% -$52.1K 0.01% 789
2023
Q3 		$458K Sell
3,130
-200
-6% -$30.5K 0.01% 764
2023
Q2 		$510K Sell
3,330
-330
-9% -$51.5K 0.01% 732
2023
Q1 		$567K Sell
3,660
-49
-1% -$7.7K 0.01% 681
2022
Q4 		$572K Sell
3,709
-540
-13% -$79.7K 0.01% 650
2022
Q3 		$561K Sell
4,249
-15
-0.4% -$2.1K 0.01% 665
2022
Q2 		$578K Buy
4,264
+55
+1% +$7.58K 0.01% 680
2022
Q1 		$628K Sell
4,209
-75
-2% -$11.1K 0.01% 732
2021
Q4 		$694K Buy
4,284
+500
+13% +$80.9K 0.01% 750
2021
Q3 		$628K Sell
3,784
-35
-0.9% -$5.98K 0.01% 786
2021
Q2 		$659K Buy
3,819
+55
+1% +$9.08K 0.01% 789
2021
Q1 		$604K Buy
3,764
+59
+2% +$10.1K 0.01% 787
2020
Q4 		$622K Sell
3,705
-71
-2% -$11.5K 0.01% 717
2020
Q3 		$594K Sell
3,776
-16,383
-81% -$2.68M 0.01% 686
2020
Q2 		$3.38M Buy
20,159
+17,572
+679% +$2.76M 0.07% 266
2020
Q1 		$339K Buy
2,587
+142
+6% +$20.2K 0.01% 742
2019
Q4 		$364K Sell
2,445
-388
-14% -$53.3K 0.01% 819
2019
Q3 		$351K Sell
2,833
-18,979
-87% -$2.53M 0.01% 863
2019
Q2 		$3.07M Buy
21,812
+2,084
+11% +$288K 0.07% 309
2019
Q1 		$2.98M Buy
19,728
+3,150
+19% +$453K 0.07% 312
2018
Q4 		$2.06M Buy
16,578
+14,713
+789% +$2.01M 0.06% 346
2018
Q3 		$296K Buy
1,865
+371
+25% +$56.1K 0.01% 931
2018
Q2 		$209K Buy
+1,494
New +$205K 0.01% 805
2016
Q1 		– Sell
-9,604
Closed -$1.08M – 766
2015
Q4 		$1.08M Sell
9,604
-851
-8% -$91.6K 0.05% 322
2015
Q3 		$1.06M Sell
10,455
-582
-5% -$69.2K 0.06% 324
2015
Q2 		$1.37M Sell
11,037
-1,264
-10% -$153K 0.06% 306
2015
Q1 		$1.45M Buy
12,301
+335
+3% +$37.9K 0.07% 293
2014
Q4 		$1.22M Sell
11,966
-4,239
-26% -$414K 0.06% 309
2014
Q3 		$1.49M Buy
16,205
+692
+4% +$60K 0.07% 277
2014
Q2 		$1.28M Sell
15,513
-24,723
-61% -$1.89M 0.06% 283
2014
Q1 		$3.09M Sell
40,236
-530
-1% -$41.4K 0.17% 155
2013
Q4 		$2.82M Sell
40,766
-1,382
-3% -$90.7K 0.14% 162
2013
Q3 		$2.73M Buy
42,148
+1,070
+3% +$67.7K 0.15% 147
2013
Q2 		$2.39M Buy
+41,078
New +$2.35M 0.13% 145

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Stephens Inc's FBT Position: Q2 2026 in Review

Stephens Inc held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 1,494 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Stephens Inc first reported a position in FBT in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.38M in Q2 2020. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Stephens Inc held 1,494 shares of First Trust NYSE Arca Biotechnology Index Fund worth $370K as of Q2 2026.
  • Stephens Inc left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Stephens Inc's portfolio in Q2 2026, its #995 holding.
  • Stephens Inc first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 44 quarters since.
  • Stephens Inc's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.38M in Q2 2020.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.